Focus on quality and growth drivers

Regardless of the challenges due to global circumstances in 2023, Galenika successfully ensured the production and distribution of its products to all markets where it operates. Priorities for 2024 remain the same - the commitment to quality, innovation, portfolio expansion, investments, and further globalization of business. 

Ricardo Vian Marques, general manager of the pharmaceutical company Galenika, spoke about it for CorD magazine, and the entire interview is available at this link.